Aktis Oncology Inc. logo

Aktis Oncology Inc.

AKTS | NASDAQ
Chart Builder DCF Calculator
$14.47
-$1.46 (-9.17%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Net Income
-24.14M -18.33M -15.14M -15.53M -18.08M -14.99M -12.06M
Depreciation & Amortization
879K 652K 695K 598K 552K 484K 441K
Stock-Based Compensation
n/a 3.02M 1.1M 1.28M 1.52M 1.24M 1.05M
Other Working Capital
-233K -7.89M -1.58M -1.42M 1.43M -2.65M -1.19M
Other Non-Cash Items
2.19M -529K -705K -749K -1.32M -1.85M -1.67M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
489K -9.06M -1.19M -820K 1.14M -2.36M -567K
Operating Cash Flow
-20.59M -24.24M -15.24M -15.22M -16.18M -17.48M -12.8M
Capital Expenditures
-1.26M -1.85M -4.15M -2M -1.54M -1.89M -2.23M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-300.45M n/a -183.05M n/a n/a -10.82M -204.87M
Sales Maturities Of Investments
33M 22.4M 60.75M 87.24M 69.68M 51.75M 34.22M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-268.71M 20.54M -126.46M 85.23M 68.15M 39.04M -172.88M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -2.26M -1.03M n/a n/a -518K -1.87M
Financial Cash Flow
156K 337.55M -772K 28K n/a -468K -1.8M
Net Cash Flow
-289.14M 333.85M -142.47M 70.04M 51.97M 21.09M -187.49M
Free Cash Flow
-21.85M -26.1M -19.4M -17.23M -17.72M -19.38M -15.03M
Adj. Free Cash Flow
-21.85M -29.12M -20.49M -18.51M -19.23M -20.61M -16.08M
Maintenance CapEx
-879K -652K n/a -2M -1.54M -1.89M -2.23M
Growth CapEx
-383K -1.2M -4.15M n/a n/a n/a n/a
Owner Earnings
-21.47M -24.89M -15.24M -17.23M -17.72M -19.38M -15.03M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.